Health & Fitness
Health and Fitness
Health and Fitness 
Wed, February 6, 2013Tue, February 5, 2013Mon, February 4, 2013Sun, February 3, 2013Sat, February 2, 2013Fri, February 1, 2013Thu, January 31, 2013Wed, January 30, 2013Tue, January 29, 2013Mon, January 28, 2013Sun, January 27, 2013Sat, January 26, 2013Fri, January 25, 2013Thu, January 24, 2013Wed, January 23, 2013Tue, January 22, 2013Mon, January 21, 2013Fri, January 18, 2013Thu, January 17, 2013Wed, January 16, 2013Tue, January 15, 2013Mon, January 14, 2013Fri, January 11, 2013Medisafe 1 Technologies Announces the Ex-Dividend Date on April 30 2013, Record Date on May 3 2013 and the Payment Date on May
Medisafe 1 Technologies Announces the Ex-Dividend Date on April 30 2013, Record Date... -- JERUSALEM, January 28, 2013 /PRNewswire/ --
JERUSALEM, January 28, 2013 /PRNewswire/ --
Medisafe 1 Technologies Corp. (OTCBB: MFTH), a developer of patented technologies that physically prevent unauthorized administration of prescription medications, announced today that the company intends to issue the one-time special dividend to all existing shareholders pursuant to the perpetual license sale of technology rights to SAFECODE DRUG TECHNOLOGIES CORP.
The dates of the dividend are as follows:
Ex-Dividend date for its dividend to its Shareholders on April 30 2013, record date on May 3 2013 and the payment date on May 6 2013.
About Medisafe 1 Technologies
Medisafe 1 Technologies seeks to effectively prevent unauthorized administration of a drug or medicinal substance by hypodermic needle. Medisafe's patented technology is a medical assembly with a locking mechanism that is intended to ensure the substance cannot be released from the hypodermic needle without positive pre-matching between the substance and its intended patient.
Forward-Looking Statements
This letter contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 as amended and Section 21E of the Securities Exchange Act of 1934 as amended. All forward-looking statements are inherently uncertain, based on current expectations and assumptions concerning future events or future performance of Medisafe 1 Technologies Corp., and its technologies. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release, as actual results may differ materially from those indicated. Medisafe 1 Technologies Corp. public filings may be viewed at [ http://www.sec.gov ].
Contact:
Jacob Elhadad , CEO
+972-524440000
[ Jacob.elhadad10@gmail.com ]
SOURCE Medisafe 1 Technologies Corp.
